| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The human serum metabolome.
|
PLoS One
|
2011
|
5.55
|
|
2
|
Soluble epoxide hydrolase is a therapeutic target for acute inflammation.
|
Proc Natl Acad Sci U S A
|
2005
|
4.07
|
|
3
|
Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.
|
J Nutr
|
2009
|
3.32
|
|
4
|
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.
|
Biochem Pharmacol
|
2002
|
2.86
|
|
5
|
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
|
Hypertension
|
2005
|
2.76
|
|
6
|
Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
|
J Am Soc Nephrol
|
2004
|
2.59
|
|
7
|
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
|
Circ Res
|
2006
|
2.33
|
|
8
|
Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women.
|
PLoS One
|
2010
|
2.14
|
|
9
|
Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease.
|
Nat Neurosci
|
2008
|
2.09
|
|
10
|
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.
|
J Biol Chem
|
2006
|
1.95
|
|
11
|
Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways.
|
J Lipid Res
|
2012
|
1.79
|
|
12
|
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.
|
Hum Mol Genet
|
2006
|
1.74
|
|
13
|
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation.
|
J Lipid Res
|
2008
|
1.71
|
|
14
|
An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
|
J Cardiovasc Pharmacol
|
2005
|
1.59
|
|
15
|
Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters.
|
J Lipid Res
|
2009
|
1.42
|
|
16
|
Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats.
|
Am J Physiol Endocrinol Metab
|
2009
|
1.37
|
|
17
|
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
|
Clin Sci (Lond)
|
2009
|
1.34
|
|
18
|
Increased blood pressure in mice lacking cytochrome P450 2J5.
|
FASEB J
|
2008
|
1.30
|
|
19
|
Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase.
|
Biochemistry
|
2005
|
1.21
|
|
20
|
Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery.
|
Anal Bioanal Chem
|
2012
|
1.18
|
|
21
|
In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.
|
Drug Metab Dispos
|
2003
|
1.14
|
|
22
|
Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers.
|
J Lipid Res
|
2012
|
1.12
|
|
23
|
imDEV: a graphical user interface to R multivariate analysis tools in Microsoft Excel.
|
Bioinformatics
|
2012
|
1.12
|
|
24
|
Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids.
|
PLoS One
|
2012
|
1.09
|
|
25
|
Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells.
|
J Am Coll Nutr
|
2003
|
1.06
|
|
26
|
Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
|
Bioorg Med Chem Lett
|
2006
|
1.05
|
|
27
|
IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal.
|
Circ Res
|
2012
|
1.04
|
|
28
|
Impact of circulating esterified eicosanoids and other oxylipins on endothelial function.
|
Curr Atheroscler Rep
|
2009
|
1.03
|
|
29
|
Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins.
|
Prostaglandins Leukot Essent Fatty Acids
|
2008
|
1.02
|
|
30
|
Genetic contribution of the leukotriene pathway to coronary artery disease.
|
Hum Genet
|
2011
|
0.96
|
|
31
|
12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms.
|
Atherosclerosis
|
2011
|
0.95
|
|
32
|
Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria.
|
Obes Res
|
2004
|
0.93
|
|
33
|
Development of metabolically stable inhibitors of Mammalian microsomal epoxide hydrolase.
|
Chem Res Toxicol
|
2008
|
0.93
|
|
34
|
Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study.
|
BMC Med Genomics
|
2010
|
0.89
|
|
35
|
Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice.
|
Am J Respir Cell Mol Biol
|
2014
|
0.89
|
|
36
|
Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women.
|
J Lipid Res
|
2011
|
0.89
|
|
37
|
Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.
|
J Pharmacol Exp Ther
|
2005
|
0.89
|
|
38
|
Fatty acid composition of liver, adipose tissue, spleen, and heart of mice fed diets containing t10, c12-, and c9, t11-conjugated linoleic acid.
|
Prostaglandins Leukot Essent Fatty Acids
|
2006
|
0.87
|
|
39
|
Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice.
|
Metabolomics
|
2007
|
0.86
|
|
40
|
Methylmalonic acid quantification in low serum volumes by UPLC-MS/MS.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2011
|
0.85
|
|
41
|
Web-enabled and improved software tools and data are needed to measure nutrient intakes and physical activity for personalized health research.
|
J Nutr
|
2010
|
0.84
|
|
42
|
ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation.
|
J Lipid Res
|
2011
|
0.83
|
|
43
|
Vitamin B-12 supplementation of rural Mexican women changes biochemical vitamin B-12 status indicators but does not affect hematology or a bone turnover marker.
|
J Nutr
|
2012
|
0.83
|
|
44
|
Plasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets.
|
J Lipid Res
|
2013
|
0.83
|
|
45
|
Arachidonate 5-lipoxygenase gene variants affect response to fish oil supplementation by healthy African Americans.
|
J Nutr
|
2012
|
0.82
|
|
46
|
Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism.
|
Toxicol Sci
|
2004
|
0.82
|
|
47
|
The effect of docosahexaenoic acid on t10, c12-conjugated linoleic acid-induced changes in fatty acid composition of mouse liver, adipose, and muscle.
|
Metab Syndr Relat Disord
|
2012
|
0.81
|
|
48
|
Graded effects of proteinuria on HDL structure in nephrotic rats.
|
J Am Soc Nephrol
|
2005
|
0.81
|
|
49
|
Congener-based Aroclor quantification and speciation techniques: a comparison of the strengths, weaknesses, and proper use of two alternative approaches.
|
Environ Sci Technol
|
2003
|
0.80
|
|
50
|
Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol.
|
BMC Cardiovasc Disord
|
2013
|
0.80
|
|
51
|
Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model.
|
Int J Oncol
|
2011
|
0.80
|
|
52
|
Effects of dynamic exercise on plasma arachidonic acid epoxides and diols in human volunteers.
|
Int J Sport Nutr Exerc Metab
|
2011
|
0.80
|
|
53
|
Association between subcutaneous white adipose tissue and serum 25-hydroxyvitamin D in overweight and obese adults.
|
Nutrients
|
2013
|
0.79
|
|
54
|
Salt loading increases urinary excretion of linoleic acid diols and triols in healthy human subjects.
|
Hypertension
|
2008
|
0.79
|
|
55
|
Daily consumption of orange-fleshed sweet potato for 60 days increased plasma β-carotene concentration but did not increase total body vitamin A pool size in Bangladeshi women.
|
J Nutr
|
2012
|
0.78
|
|
56
|
Direct comparison of fatty acid ratios in single cellular lipid droplets as determined by comparative Raman spectroscopy and gas chromatography.
|
Analyst
|
2013
|
0.78
|
|
57
|
Variation in metabolic responses to meal challenges differing in glycemic index in healthy women: Is it meaningful?
|
Nutr Metab (Lond)
|
2012
|
0.77
|
|
58
|
Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.
|
Int J Oncol
|
2012
|
0.77
|
|
59
|
Habitual diets rich in dark-green vegetables are associated with an increased response to ω-3 fatty acid supplementation in Americans of African ancestry.
|
J Nutr
|
2013
|
0.76
|
|
60
|
Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model.
|
Int J Oncol
|
2012
|
0.75
|
|
61
|
Effects of pyridine exposure upon structural lipid metabolism in Swiss Webster mice.
|
Chem Res Toxicol
|
2008
|
0.75
|